Cargando…

Liver cirrhosis in England—an observational study: are we measuring its burden occurrence correctly?

OBJECTIVES: Mortality due to liver disease (of which cirrhosis is the end stage) is increasing more than any other chronic condition in the UK. This study aims to demonstrate that (1) exclusive reliance on mortality rates may not reveal the true burden of liver cirrhosis, and (2) diverse use of diag...

Descripción completa

Detalles Bibliográficos
Autores principales: Ratib, Sonia, West, Joe, Fleming, Kate M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5541611/
https://www.ncbi.nlm.nih.gov/pubmed/28710203
http://dx.doi.org/10.1136/bmjopen-2016-013752
_version_ 1783254846465376256
author Ratib, Sonia
West, Joe
Fleming, Kate M
author_facet Ratib, Sonia
West, Joe
Fleming, Kate M
author_sort Ratib, Sonia
collection PubMed
description OBJECTIVES: Mortality due to liver disease (of which cirrhosis is the end stage) is increasing more than any other chronic condition in the UK. This study aims to demonstrate that (1) exclusive reliance on mortality rates may not reveal the true burden of liver cirrhosis, and (2) diverse use of diagnostic coding may produce misleading estimates. DESIGN: Observational study. SETTING: The Office for National Statistics death registry was interrogated to investigate liver cirrhosis mortality trends in England and Wales from 1968 to 2011. MAIN OUTCOME: Standardised mortality trends according to three different definitions of liver cirrhosis based on the specificity of diagnostic codes were calculated: 1 (chronic liver diseases), 2 (alcoholic and unspecified cirrhosis only) and 3 (cirrhosis as end-stage liver disease). The mortality trends were compared with incidence rates established in a previous population-based study (based on definition 3), from 1998 to 2009, to investigate discrepancies between these two measures. RESULTS: Over the study period, the overall standardised liver cirrhosis mortality rates were 8.8, 5,1 and 5.4 per 100 000 person-years for definitions 1, 2 and 3, respectively. The mortality rates for definition 3 in 1998 and 2009 were 6.2 and 5.9 per 100 000 person-years, respectively; while the equivalent incidence rates were at least threefold and sixfold higher: 23.4 and 35.9 per 100 000 person-years, respectively. This discrepancy between incidence and mortality rates was also at least threefold in men and women separately and across age groups. CONCLUSION: Mortality rates underestimated the incidence of liver cirrhosis by at least threefold between 1998 and 2009 and varied with differing definitions of disease. Mortality data should not be used exclusively as an indicator for the occurrence of liver cirrhosis in the population. Routinely collected healthcare data are available to measure occurrence of this disease. Careful consideration should be taken when selecting diagnostic codes for cirrhosis.
format Online
Article
Text
id pubmed-5541611
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-55416112017-08-18 Liver cirrhosis in England—an observational study: are we measuring its burden occurrence correctly? Ratib, Sonia West, Joe Fleming, Kate M BMJ Open Gastroenterology and Hepatology OBJECTIVES: Mortality due to liver disease (of which cirrhosis is the end stage) is increasing more than any other chronic condition in the UK. This study aims to demonstrate that (1) exclusive reliance on mortality rates may not reveal the true burden of liver cirrhosis, and (2) diverse use of diagnostic coding may produce misleading estimates. DESIGN: Observational study. SETTING: The Office for National Statistics death registry was interrogated to investigate liver cirrhosis mortality trends in England and Wales from 1968 to 2011. MAIN OUTCOME: Standardised mortality trends according to three different definitions of liver cirrhosis based on the specificity of diagnostic codes were calculated: 1 (chronic liver diseases), 2 (alcoholic and unspecified cirrhosis only) and 3 (cirrhosis as end-stage liver disease). The mortality trends were compared with incidence rates established in a previous population-based study (based on definition 3), from 1998 to 2009, to investigate discrepancies between these two measures. RESULTS: Over the study period, the overall standardised liver cirrhosis mortality rates were 8.8, 5,1 and 5.4 per 100 000 person-years for definitions 1, 2 and 3, respectively. The mortality rates for definition 3 in 1998 and 2009 were 6.2 and 5.9 per 100 000 person-years, respectively; while the equivalent incidence rates were at least threefold and sixfold higher: 23.4 and 35.9 per 100 000 person-years, respectively. This discrepancy between incidence and mortality rates was also at least threefold in men and women separately and across age groups. CONCLUSION: Mortality rates underestimated the incidence of liver cirrhosis by at least threefold between 1998 and 2009 and varied with differing definitions of disease. Mortality data should not be used exclusively as an indicator for the occurrence of liver cirrhosis in the population. Routinely collected healthcare data are available to measure occurrence of this disease. Careful consideration should be taken when selecting diagnostic codes for cirrhosis. BMJ Publishing Group 2017-07-13 /pmc/articles/PMC5541611/ /pubmed/28710203 http://dx.doi.org/10.1136/bmjopen-2016-013752 Text en © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Gastroenterology and Hepatology
Ratib, Sonia
West, Joe
Fleming, Kate M
Liver cirrhosis in England—an observational study: are we measuring its burden occurrence correctly?
title Liver cirrhosis in England—an observational study: are we measuring its burden occurrence correctly?
title_full Liver cirrhosis in England—an observational study: are we measuring its burden occurrence correctly?
title_fullStr Liver cirrhosis in England—an observational study: are we measuring its burden occurrence correctly?
title_full_unstemmed Liver cirrhosis in England—an observational study: are we measuring its burden occurrence correctly?
title_short Liver cirrhosis in England—an observational study: are we measuring its burden occurrence correctly?
title_sort liver cirrhosis in england—an observational study: are we measuring its burden occurrence correctly?
topic Gastroenterology and Hepatology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5541611/
https://www.ncbi.nlm.nih.gov/pubmed/28710203
http://dx.doi.org/10.1136/bmjopen-2016-013752
work_keys_str_mv AT ratibsonia livercirrhosisinenglandanobservationalstudyarewemeasuringitsburdenoccurrencecorrectly
AT westjoe livercirrhosisinenglandanobservationalstudyarewemeasuringitsburdenoccurrencecorrectly
AT flemingkatem livercirrhosisinenglandanobservationalstudyarewemeasuringitsburdenoccurrencecorrectly